Former senior sales director Darren Winter has joined Frontier IP to support its portfolio companies with fundraising.

USF's senior vice-president for research and innovation Paul Sanberg will return to being a distinguished professor in neurosurgery and brain repair.

The eye disease device developer has raised series B funding to advance research originating from University of Colorado's s Sue Anschutz-Rodgers Eye Center.

Four of the incubator’s portfolio companies will pitch to investors at the GCV Digital Forum 3.0 following the success of similar competitions at our previous events.

Weill Cornell Medicine‘s monogenic diseases therapy developer Lexeo Therapeutics has made its public debut with $85m in series A financing.

LifeMine’s chairman and co-founder Rick Klausner has co-led a round that included multiple corporates and pushed the overall equity to $120m.

Life sciences veteran Gerald J Vardzel has been named president and CEO of University of Pittsburgh’s LifeX Labs.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The brain disease treatment developer was founded in 2019 on the back of more than a decade’s collaborative research from MIT and Harvard.

IP Group subsidiary Parkwalk Advisors is to pour even more funding into the UK's academic deep tech research under a new government tax scheme.